Company Name or Ticker Symbol
Search for other Categories

Sarepta Therapeutics, Inc.  (SRPT)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations

SRPT's Revenue Year on Year Growth by Quarter and Year

Sarepta Therapeutics,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
SRPT Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 5.42 1.25 -1.84
III Quarter September - - - 1.06
II Quarter June 35.01 - - 2.58
I Quarter March 16.34 - - 6.09
FY   51.35 5.42 1.25 7.89

Financial Statements
Sarepta Therapeutics,'s second quarter 2017 Revenue $ 35.01 millions SRPT's Income Statement
Sarepta Therapeutics,'s second quarter 2016 Revenue $ 0.00 millions Quarterly SRPT's Income Statement
SRPT's Growth by Division See SRPT's Growth by Segment

SRPT Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 333.6 % - -
III Quarter September - - - -74.58 %
II Quarter June - - - -12.54 %
I Quarter March - - - 36.24 %
FY   - 333.6 % -84.16 % -

SRPT Revenue Growth Comment
Sarepta Therapeutics, Inc. in the second quarter achieved Revenue of $ 35.01 millions compare to recorded in same quarter a year ago.

According to the results reported in the second quarter, Sarepta Therapeutics, Inc. achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Sarepta Therapeutics, Inc.' s Revenue no change of % ranks overall at the positon no. 0 in the second quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
332.64 % -7.91 % -100 %
(Dec 31 2016)   (Sep 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SRPT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SRPT's Competitors
Revenue Growth for Sarepta Therapeutics,'s Suppliers
Revenue Growth for SRPT's Customers

You may also want to know
SRPT's Annual Growth Rates SRPT's Profitability Ratios SRPT's Asset Turnover Ratio SRPT's Dividend Growth
SRPT's Roe SRPT's Valuation Ratios SRPT's Financial Strength Ratios SRPT's Dividend Payout Ratio
SRPT's Roa SRPT's Inventory Turnover Ratio SRPT's Growth Rates SRPT's Dividend Comparisons

Companies with similar Revenue no change for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Fate Therapeutics Inc -0.10 %$ -0.097 millions
Psychemedics Corp -0.17 %$ -0.165 millions
Halyard Health, Inc. -0.20 %$ -0.200 millions
Xtant Medical Holdings, Inc. -0.25 %$ -0.249 millions
Ocular Therapeutix, Inc. -0.68 %$ -0.680 millions
Emergent Biosolutions Inc. -0.70 %$ -0.705 millions
Tenet Healthcare Corp -0.90 %$ -0.900 millions
Integrated Biopharma Inc -1.21 %$ -1.212 millions
Genmark Diagnostics, Inc. -1.22 %$ -1.223 millions
Trovagene, Inc. -1.34 %$ -1.343 millions
Mymetics Corp -1.86 %$ -1.858 millions
Vaso Corp -1.98 %$ -1.982 millions
Recro Pharma, Inc. -2.00 %$ -1.997 millions
Inc Research Holdings, Inc. -2.13 %$ -2.130 millions
Quorum Health Corporation -2.16 %$ -2.165 millions
China Biologic Products Holdings, Inc. -2.34 %$ -2.344 millions
Msa Safety Incorporated -2.44 %$ -2.440 millions
Pacific Biosciences Of California, Inc. -3.25 %$ -3.249 millions
T2 Biosystems, Inc. -3.43 %$ -3.434 millions
Therapeuticsmd, Inc. -3.47 %$ -3.470 millions
Harvard Bioscience Inc -3.53 %$ -3.532 millions
Twinlab Consolidated Holdings, Inc. -3.61 %$ -3.614 millions
Acceleron Pharma Inc -4.32 %$ -4.319 millions
Conformis Inc -4.39 %$ -4.391 millions
Lifevantage Corp -4.51 %$ -4.510 millions
Endologix Inc -4.74 %$ -4.744 millions
Steris Plc -4.76 %$ -4.764 millions
China Senior Living Industry International Holding -4.88 %$ -4.883 millions
Becton Dickinson & Co -5.10 %$ -5.097 millions
Cancer Genetics, Inc -5.67 %$ -5.671 millions


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

ELED's Profile

Stock Price

ELED's Financials

ELED's Expectations

Business Description


Charts & Quotes

ELED's News


ELED's Competitors

Customers & Markets

Economic Indicators

ELED's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength



Management Effectivness


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com